Skip to main content
. Author manuscript; available in PMC: 2016 Apr 18.
Published in final edited form as: Scand J Gastroenterol. 2015 May 21;50(11):1382–1388. doi: 10.3109/00365521.2015.1050692

Table 1.

Baseline characteristics of the patients in two subtypes of microscopic colitis a

Histological subtype P value
Lymphocytic colitis (n=55) Collagenous colitis (n=76)
Age (years) Mean (SD) 59.9 (20.8) 61.3 (15.1) 0.72
BMI (Kg/m2) Mean (SD) 25.8 (5.2) 24.7 (4.6) 0.38
Sex
 Female %(n) 69.1 (38) 85.5 (65) 0.03
Race
 White %(n) 90.9 (50) 94.7 (71) 0.49
Abdominal Pain %(n) 41.8 (23) 32.0 (24) 0.27
Weight Loss %(n) 27.3 (15) 30.7 (23) 0.70
Type 2 Diabetes
Mellitus %(n) 18.2 (10) 5.3 (4) 0.02
Autoimmune disease %(n) 41.8 (23) 42.7 (32) 1.00
 Hashimoto’s disease 47.8 (11) 37.5 (12) 0.58
 Celiac disease 17.4 (4) 28.1 (9) 0.52
 Othersb 60.9 (14) 59.4 (19) 1.00
GERD %(n) 38.2 (21) 41.3 (31) 0.86
Smoke %(n) 23.6 (13) 15.8 (12) 0.27
ESR (mm/h) Mean (SD) 13.3 (19.3) 28.2 (18.6) 0.04
SSRIsc %(n) 36.4 (20) 27.8 (20) 0.34
NSAIDsc %(n) 38.2 (21) 54.9 (39) 0.07
Antibioticsc %(n) 16.4 (9) 20.8 (15) 0.65
PPIsc %(n) 38.2 (21) 34.7 (25) 0.71
Statinsc %(n) 21.8 (12) 23.6 (17) 0.83
a

Abbreviations: SD = Standard deviation; GERD = Gastro esophageal reflux; ESR = Erythrocyte sedimentation rate; SSRIs = Selective serotonin reuptake inhibitors; NSAIDs = Non-steroidal anti-inflammatory drugs; PPIs = Proton pump inhibitors.

b

Psoriasis, Type 1 Diabetes Mellitus, Rheumatoid arthritis, Grave’s disease, Sjögren’s disease, and unspecified immune disease disorder.

c

Defined as use up to one month prior to onset of symptoms.